Changes in the Multiple Sclerosis Treatment Paradigm. What Do We Do Now and What Were We Doing Before?

BACKGROUND AND PURPOSE: The number of disease-modifying drugs (DMDs) available for treating relapsing-remitting multiple sclerosis is increasing. Numerous drugs have been approved since 2010 in South America, which has increased the complexity of the treatment algorithm. The aim of this study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Alonso, Ricardo, Eizaguirre, María Bárbara, Zavala, Lucía, Pita, Cecilia, Silva, Berenice, Garcea, Orlando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurological Association 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172498/
https://www.ncbi.nlm.nih.gov/pubmed/30198224
http://dx.doi.org/10.3988/jcn.2018.14.4.487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6172498/
https://www.ncbi.nlm.nih.gov/pubmed/30198224
http://dx.doi.org/10.3988/jcn.2018.14.4.487

Ejemplares similares